rxstatShortages › Finasteride

Finasteride (Proscar, Propecia) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Finasteride products are in shortage in Canada (2 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 31, 2026.

A medication used to treat an enlarged prostate and male pattern hair loss.

Products affected
2 / 18
In shortage since
Feb 13, 2024
Est. full return
Dec 31, 2026
Reports on file
68
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
JAMP-FINASTERIDE
5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02357224 · since Aug 23, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-FINASTERIDE
5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02357224 · since Aug 23, 2024, est. end Dec 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-FINASTERIDE
5MG · TABLET · APOTEX INC
DIN 02365383 · since Feb 13, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
TEVA-FINASTERIDE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02348500 · ended Apr 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-FINASTERIDE
5MG · TABLET · TEVA CANADA LIMITED
DIN 02348500 · ended Mar 4, 2026 · Disruption of the manufacture of the drug.
Resolved
ACH-FINASTERIDE
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02355043 · ended Feb 13, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-FINASTERIDE
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02355043 · ended Feb 2, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
FINASTERIDE
5MG · TABLET · SANIS HEALTH INC
DIN 02445077 · ended Jun 25, 2025 · Disruption of the manufacture of the drug.
Resolved
FINASTERIDE
5MG · TABLET · SANIS HEALTH INC
DIN 02445077 · ended Jun 23, 2025 · Disruption of the manufacture of the drug.
Discontinued
SANDOZ FINASTERIDE
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02322579
Resolved
SANDOZ FINASTERIDE
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02322579 · ended Apr 1, 2025 · Disruption of the manufacture of the drug.
Discontinued
SANDOZ FINASTERIDE
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02322579

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Finasteride is currently affected by 2 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Finasteride is classified under “DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY” (ATC G04CB).

Recent changes

Common questions

What is Finasteride used for?

A medication used to treat an enlarged prostate and male pattern hair loss.

When will Finasteride be back in stock in Canada?

The latest manufacturer estimate is Dec 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Finasteride in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (drugs used in benign prostatic hypertrophy)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.